Artemisia laevigata lactone I derivative, pharmaceutical composition thereof, preparation method and application of artemisia laevigata lactone I derivative
The invention provides 33 abelmoschus laevigatus lactone I derivatives 1-33 as shown in a structural formula (I) as well as a pharmaceutical composition, a preparation method and application thereof, and belongs to the technical field of medicines. The artemisia lavandulolactone I derivatives 1-33 p...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
14.06.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention provides 33 abelmoschus laevigatus lactone I derivatives 1-33 as shown in a structural formula (I) as well as a pharmaceutical composition, a preparation method and application thereof, and belongs to the technical field of medicines. The artemisia lavandulolactone I derivatives 1-33 provided by the invention have obvious inhibitory activity on human hepatoma cell lines (HepG2, Huh7 and SK-Hep-1), can form a pharmaceutical composition with a pharmaceutically acceptable carrier, and can be used for preparing anti-hepatoma drugs.
本发明提供结构式(I)所示33个野艾蒿内酯I衍生物1-33及其药物组合物和其制备方法与应用,属于药物技术领域。本发明的野艾蒿内酯I衍生物1-33对人肝癌细胞株(HepG2,Huh7,SK-Hep-1)具有明显的抑制活性,能够与可药用载体组成药物组合物,能够用于制备抗肝癌药物。 |
---|---|
Bibliography: | Application Number: CN202410295603 |